Brown Advisory Securities’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Brown Advisory Securities’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-25,000	Closed	-$207K	–	251
2019 Q3	$207K	Hold	25,000	–	–	0.06%	215
2019 Q2	$215K	Hold	25,000	–	–	0.06%	225
2019 Q1	$267K	Hold	25,000	–	–	0.06%	229
2018 Q4	$231K	Hold	25,000	–	–	0.04%	303
2018 Q3	$420K	Hold	25,000	–	–	0.07%	237
2018 Q2	$524K	Hold	25,000	–	–	0.09%	203
2018 Q1	$402K	Hold	25,000	–	–	0.07%	243
2017 Q4	$474K	Hold	25,000	–	–	0.09%	212
2017 Q3	$352K	Hold	25,000	–	–	0.08%	233
2017 Q2	$186K	Buy	+25,000	New	+$163K	0.04%	315

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Advisory Securities's SPPI Position: Q4 2019 in Review

Brown Advisory Securities sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2019, closing a stake of 25,000 shares — an estimated $207K sold.

Brown Advisory Securities first reported a position in SPPI in Q2 2017 and held it in 10 quarters. The position peaked at $524K in Q2 2018. 169 funds tracked by Wall St. Rank hold SPPI as of Q4 2019.

Brown Advisory Securities reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
Brown Advisory Securities sold 25,000 Spectrum Pharmaceuticals Inc shares in Q4 2019, an estimated $207K.
Brown Advisory Securities first reported a position in Spectrum Pharmaceuticals Inc in Q2 2017 and held it in 10 quarters.
Brown Advisory Securities's Spectrum Pharmaceuticals Inc position peaked at $524K in Q2 2018.
169 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2019.

Based on Brown Advisory Securities's 13F filing for Q4 2019, filed 14 Feb 2020.